Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use
Women are at increased risk for cardiovascular disease (CVD) compared with men. While traditional risk factors for CVD seem to disproportionately affect women and contribute to this disparity, increased prevalence of CVD at midlife calls into question the contribution of menopause. Given the potenti...
Main Authors: | Sindhu Prabakaran, Arielle Schwartz, Gina Lundberg |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-04-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/20420188211013917 |
Similar Items
-
Menopause and menopausal hormone therapy in women: cardiovascular benefits and risks
by: Anna Svatikova, et al.
Published: (2018-01-01) -
Menopausal hormone therapy (MHT): the current thinking, the benefits, and the risks
by: M. Wattegama, et al.
Published: (2021-04-01) -
MENOPAUSE AND CARDIOVASCULAR RISK
by: D. A. Anichkov, et al.
Published: (2015-12-01) -
MENOPAUSE AND CARDIOVASCULAR RISK
by: D. A. Anichkov, et al.
Published: (2015-12-01) -
Risks, Benefits, and Treatment Modalities of Menopausal Hormone Therapy: Current Concepts
by: Jaya Mehta, et al.
Published: (2021-03-01)